LeMaitre Vascular (LMAT) Reaches $29.88 After 5.00% Up Move; Global Endowment Management LP Has Lifted Its Corporate Office Pptys Tr (OFC) Stake

July 17, 2017 - By Maria Brooks

The stock of LeMaitre Vascular Inc (NASDAQ:LMAT) is a huge mover today! About 91,546 shares traded. LeMaitre Vascular Inc (NASDAQ:LMAT) has risen 101.07% since July 17, 2016 and is uptrending. It has outperformed by 84.37% the S&P500.The move comes after 9 months positive chart setup for the $563.76M company. It was reported on Jul, 17 by Barchart.com. We have $31.37 PT which if reached, will make NASDAQ:LMAT worth $28.19M more.

Global Endowment Management Lp increased Corporate Office Pptys Tr (OFC) stake by 110.42% reported in 2016Q4 SEC filing. Global Endowment Management Lp acquired 43,350 shares as Corporate Office Pptys Tr (OFC)’s stock rose 0.60%. The Global Endowment Management Lp holds 82,610 shares with $2.58 million value, up from 39,260 last quarter. Corporate Office Pptys Tr now has $3.46 billion valuation. The stock rose 1.07% or $0.37 reaching $34.91 per share. About 239,421 shares traded. Corporate Office Properties Trust (NYSE:OFC) has risen 30.32% since July 17, 2016 and is uptrending. It has outperformed by 13.62% the S&P500.

Among 12 analysts covering Corporate Office Properties Trust (NYSE:OFC), 2 have Buy rating, 0 Sell and 10 Hold. Therefore 17% are positive. Corporate Office Properties Trust had 25 analyst reports since July 29, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the shares of OFC in report on Wednesday, December 23 with “Sell” rating. Jefferies maintained Corporate Office Properties Trust (NYSE:OFC) rating on Tuesday, May 30. Jefferies has “Hold” rating and $3600 target. The stock of Corporate Office Properties Trust (NYSE:OFC) has “Hold” rating given on Monday, July 3 by Jefferies. JP Morgan maintained Corporate Office Properties Trust (NYSE:OFC) on Monday, August 15 with “Neutral” rating. The rating was downgraded by Robert W. Baird on Wednesday, February 15 to “Neutral”. The stock has “Hold” rating by Stifel Nicolaus on Friday, July 14. As per Wednesday, July 29, the company rating was downgraded by Stifel Nicolaus. BTIG Research initiated the stock with “Buy” rating in Thursday, August 25 report. The rating was maintained by RBC Capital Markets with “Sector Perform” on Thursday, July 30. Mizuho downgraded the shares of OFC in report on Monday, July 10 to “Neutral” rating.

Investors sentiment decreased to 1.06 in 2016 Q4. Its down 0.11, from 1.17 in 2016Q3. It turned negative, as 22 investors sold OFC shares while 82 reduced holdings. 31 funds opened positions while 79 raised stakes. 99.04 million shares or 8.23% more from 91.51 million shares in 2016Q3 were reported. Blackrock Investment Mngmt Ltd Liability Co holds 0.01% of its portfolio in Corporate Office Properties Trust (NYSE:OFC) for 335,547 shares. Adelante Cap Mngmt Ltd Com invested in 0.82% or 528,300 shares. Jacobs Levy Equity holds 0.02% or 38,980 shares in its portfolio. Bessemer Gp reported 0% of its portfolio in Corporate Office Properties Trust (NYSE:OFC). Td Asset Mngmt holds 0% or 37,700 shares in its portfolio. 11,531 are held by Panagora Asset Management. Qs Investors Ltd Company owns 0% invested in Corporate Office Properties Trust (NYSE:OFC) for 4,769 shares. Aperio Group Ltd Co has invested 0.01% in Corporate Office Properties Trust (NYSE:OFC). Raymond James Assocs reported 0% in Corporate Office Properties Trust (NYSE:OFC). 1.21M were reported by Fmr Ltd Liability Corporation. Glenmede Communications Na has invested 0.02% in Corporate Office Properties Trust (NYSE:OFC). Advsrs Asset Mngmt Inc holds 34,767 shares. Pacific Heights Asset Mgmt Limited Liability holds 0.37% of its portfolio in Corporate Office Properties Trust (NYSE:OFC) for 125,000 shares. Blackrock Institutional Tru Na holds 3.93M shares. Utd Ser Automobile Association reported 330,390 shares stake.

Since February 7, 2017, it had 0 buys, and 6 insider sales for $892,482 activity. DENTON ROBERT L also sold $328,379 worth of Corporate Office Properties Trust (NYSE:OFC) shares. The insider Thor Greg J sold $120,941. The insider JACOBSTEIN DAVID M sold 3,118 shares worth $104,576.

Global Endowment Management Lp decreased Gilead Sciences Inc (NASDAQ:GILD) stake by 6,300 shares to 39,640 valued at $2.84M in 2016Q4. It also reduced Stericycle Inc (NASDAQ:SRCL) stake by 9,200 shares and now owns 37,280 shares. Berkshire Hathaway Inc Del (BRKB) was reduced too.

Among 11 analysts covering LeMaitre Vascular (NASDAQ:LMAT), 7 have Buy rating, 0 Sell and 4 Hold. Therefore 64% are positive. LeMaitre Vascular had 26 analyst reports since July 29, 2015 according to SRatingsIntel. Roth Capital maintained LeMaitre Vascular Inc (NASDAQ:LMAT) on Monday, December 7 with “Buy” rating. As per Wednesday, October 28, the company rating was upgraded by Barrington Research. The rating was maintained by TH Capital on Wednesday, July 29 with “Buy”. Cowen & Co maintained LeMaitre Vascular Inc (NASDAQ:LMAT) rating on Thursday, April 21. Cowen & Co has “Outperform” rating and $93 target. The firm earned “Buy” rating on Monday, December 7 by TH Capital. Barrington Research initiated LeMaitre Vascular Inc (NASDAQ:LMAT) on Thursday, September 10 with “Mkt Perform” rating. Canaccord Genuity maintained the stock with “Buy” rating in Tuesday, May 3 report. The stock of LeMaitre Vascular Inc (NASDAQ:LMAT) earned “Mkt Perform” rating by Barrington Research on Wednesday, February 22. Canaccord Genuity downgraded the shares of LMAT in report on Monday, July 10 to “Hold” rating. The rating was maintained by Dougherty & Company with “Buy” on Monday, December 7.

Investors sentiment decreased to 1.12 in Q4 2016. Its down 0.44, from 1.56 in 2016Q3. It worsened, as 11 investors sold LeMaitre Vascular Inc shares while 39 reduced holdings. 18 funds opened positions while 38 raised stakes. 10.81 million shares or 0.20% more from 10.78 million shares in 2016Q3 were reported. Tfs Cap Limited Liability Co owns 0.36% invested in LeMaitre Vascular Inc (NASDAQ:LMAT) for 53,568 shares. Acadian Asset Limited Co accumulated 70,595 shares. Driehaus Capital Mngmt Ltd Co has invested 0.47% in LeMaitre Vascular Inc (NASDAQ:LMAT). Moreover, Needham Invest Mngmt Limited Liability Corporation has 0.18% invested in LeMaitre Vascular Inc (NASDAQ:LMAT). Citadel Advisors Lc holds 0% in LeMaitre Vascular Inc (NASDAQ:LMAT) or 8,563 shares. First Quadrant L P Ca reported 5,600 shares or 0% of all its holdings. Blackrock Fund Advsrs invested in 0% or 436,046 shares. Blackrock Inc reported 12,390 shares. Goldman Sachs Inc has invested 0% of its portfolio in LeMaitre Vascular Inc (NASDAQ:LMAT). Aqr Capital Management Limited Co holds 0.01% in LeMaitre Vascular Inc (NASDAQ:LMAT) or 162,363 shares. The Georgia-based Invesco Limited has invested 0% in LeMaitre Vascular Inc (NASDAQ:LMAT). Millennium Mgmt Lc stated it has 0.01% of its portfolio in LeMaitre Vascular Inc (NASDAQ:LMAT). Prudential Fincl reported 0% stake. Strs Ohio has invested 0% in LeMaitre Vascular Inc (NASDAQ:LMAT). Jfs Wealth Advsr Limited Liability Company invested in 0.01% or 1,000 shares.

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The company has market cap of $563.76 million. The Firm develops, makes and markets medical devices and implants used primarily in the field of vascular surgery. It has a 49.79 P/E ratio. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.

Since February 27, 2017, it had 0 insider purchases, and 9 insider sales for $8.92 million activity. 10,000 shares valued at $223,565 were sold by LeMaitre George W on Monday, February 27. 15,780 LeMaitre Vascular Inc (NASDAQ:LMAT) shares with value of $477,822 were sold by Kamke Trent G. 5,900 LeMaitre Vascular Inc (NASDAQ:LMAT) shares with value of $132,380 were sold by Roberts David B. 2,346 LeMaitre Vascular Inc (NASDAQ:LMAT) shares with value of $73,717 were sold by Wijas Michael T.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: